King's Health Partners is an academic health science centre located in London, United Kingdom. It comprises King's College London, Guy's and St Thomas' NHS Foundation Trust, King's College Hospital NHS Foundation Trust and South London and Maudsley NHS Foundation Trust.

During the past decade, King's Health Partners conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "King's Health Partners" are "AML" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "King's Health Partners" in a lesser frequency.

Most popular intervention types in "King's Health Partners" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Flotetuzumab dose escalation" (1 trials), "Flotetuzumab dose expansion" (1 trials) and "Ruxolitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "King's Health Partners" are 2 trials for "All" genders.

Currently, there are NaN active trials in "King's Health Partners". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in King's Health Partners, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in King's Health Partners, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".